Historical record - last NADAC effective date: 11/16/2022
Product Information
ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $1.5764 per EA under NDC 50742024618. Its NADAC has been published 14 times since Sep 21, 2022.
FDA first approved this application on Apr 6, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET
Isosorbide dinitrate and hydralazine hydrochlorideStrength
37.5; 20 mg/1; mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742024618
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
11/16/2022
Active Ingredients
HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA215586FDA Approved
4/6/2022
TE Code
AB
On Market Since
4/12/2022
Pharmacological Classes
Price Statistics
The NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has been published 14 times since Sep 21, 2022, and over the history we have for it it has risen 14.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5764 per EA |
|---|---|
| All-time high | $1.5764 (Dec 21, 2022) |
| All-time low | $1.3757 (Sep 21, 2022) |
| Median price | $1.3757 |
| Average price | $1.4617 |
| Largest weekly change | +14.6% (Nov 16, 2022) |
| Weeks tracked | 14 |
| Tracking since | Sep 21, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+14.6%
Last surveyed Dec 21, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 55% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $1.5764 per EA (NDC 50742024618), effective Dec 21, 2022.
How has the price of ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has risen 14.6%. It has been tracked across 14 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
Since Sep 21, 2022, the NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has ranged from a low of $1.3757 (Sep 21, 2022) to a high of $1.5764 (Dec 21, 2022), with a median of $1.3757 per EA.
Are there cheaper alternatives to ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET, is $0.7091 per EA — about 55% below ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET.
Who manufactures ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET (NDC 50742024618) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.